-
3
-
-
62349104137
-
Pathophysiologisch-orientierte Diagnostik und Therapie der Eisenmangelanämie bei chronisch entzündlichen Darmerkrankungen
-
Stein JM, Hartmann F, Cordes HJ, et al. Pathophysiologisch-orientierte Diagnostik und Therapie der Eisenmangelanämie bei chronisch entzündlichen Darmerkrankungen. Z Gastroenterol 2009;47:228-36.
-
(2009)
Z Gastroenterol
, vol.47
, pp. 228-236
-
-
Stein, J.M.1
Hartmann, F.2
Cordes, H.J.3
-
4
-
-
64349113606
-
Iron deficiency anemia: Diagnosis and management
-
Clark SF. Iron deficiency anemia: diagnosis and management. Curr Opin Gastroenteral 2009;25:122-8.
-
(2009)
Curr Opin Gastroenteral
, vol.25
, pp. 122-128
-
-
Clark, S.F.1
-
5
-
-
33750584843
-
Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis
-
DOI 10.1002/ajh.20657
-
Malyszko J, Malyszko JS, Pawlak K, et al. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation and hemodialysis. Am J Hematol 2006;81:832-7. (Pubitemid 44682184)
-
(2006)
American Journal of Hematology
, vol.81
, Issue.11
, pp. 832-837
-
-
Malyszko, J.1
Malyszko, J.S.2
Pawlak, K.3
Mysliwiec, M.4
-
6
-
-
33645291842
-
Neue Parameter zur Diagnostik von Eisenmangelzuständen
-
Thomas L, Thomas C, Heimpel H. Neue Parameter zur Diagnostik von Eisenmangelzuständen. Dt Ärzteblatt 2005;104:1580-6.
-
(2005)
Dt Ärzteblatt
, vol.104
, pp. 1580-1586
-
-
Thomas, L.1
Thomas, C.2
Heimpel, H.3
-
7
-
-
0032861760
-
Serum transferrin receptors in detection of iron deficiency in pregnancy
-
DOI 10.1007/s002770050529
-
Rusia U, Flowers C, Madan N, et al. Serum transferring receptors in detection of iron deficiency in pregnancy. Ann Hematol 1999;78:358-63. (Pubitemid 29419593)
-
(1999)
Annals of Hematology
, vol.78
, Issue.8
, pp. 358-363
-
-
Rusia, U.1
Flowers, C.2
Madan, N.3
Agarwal, N.4
Sood, S.K.5
Sikka, M.6
-
8
-
-
0024360830
-
Clinical pharmacokinetics of iron preparations
-
Harju E. Clinical pharmacokinetics of iron preparations. Clin Pharmacokinet 1989;17:69-89. (Pubitemid 19199634)
-
(1989)
Clinical Pharmacokinetics
, vol.17
, Issue.2
, pp. 69-89
-
-
Harju, E.1
-
9
-
-
0022576447
-
BIOVERFUGBARKEIT UND THERAPEUTISCHER WERT ORALER EISEN(II)- UND EISEN(III)-PRAPARATE
-
Heinrich H. Bioverfügbarkeit und therapeutischer Wert oraler Eisen(II)- und Eisen(III)-Präparate. Dtsch Apoth Ztg 1986;14:681-90. (Pubitemid 16102271)
-
(1986)
Deutsche Apotheker Zeitung
, vol.126
, Issue.14
, pp. 681-690
-
-
Heinrich, H.C.1
-
10
-
-
77951785290
-
Orange but not apple juice enhances ferrous fumarate absorption in small children
-
Balay KS, Hawthorne KM, Hicks PD, et al. Orange but not apple juice enhances ferrous fumarate absorption in small children. J Pediatr Gastroenterol Nutr 2010;50:545-50.
-
(2010)
J Pediatr Gastroenterol Nutr
, vol.50
, pp. 545-550
-
-
Balay, K.S.1
Hawthorne, K.M.2
Hicks, P.D.3
-
11
-
-
34447345399
-
Safety and efficacy of iron (III)-hydroxide polymaltose complex: A review of over 25 years experience
-
Geisser P. Safety and efficacy of iron(III)-hydroxide polymaltose complex / a review of over 25 years experience. Arzneimittelforschung 2007;57:439-52. (Pubitemid 47055995)
-
(2007)
Arzneimittel-Forschung/Drug Research
, vol.57
, Issue.6 A
, pp. 439-452
-
-
Geisser, P.1
-
12
-
-
0034095717
-
Better tolerance of iron polymaltose complex compared with ferrous sulphate in the treatment of anaemia
-
Jacobs P, Wood L, Bird AR. Better tolerance of iron polymaltose complex compared with ferrous sulphate in the treatment of anemia. Hematology 2000;5:77-83. (Pubitemid 30410508)
-
(2000)
Hematology
, vol.5
, Issue.1
, pp. 77-83
-
-
Jacobs, P.1
Wood, L.2
Bird, A.R.3
-
13
-
-
0033181106
-
Oral supplementation with ferrous sulfate but not with nonionic iron polymaltose complex increases the susceptibility of plasma lipoproteins to oxidation
-
DOI 10.1016/S0271-5317(99)00073-1, PII S0271531799000731
-
Tuomainen TP, Nyyssönen K, Porkkala-Sarataho E, et al. Oral supplementation with ferrous transfer but not with non-ionic iron polymaltose complex increases the susceptibility of plasma lipoproteins to oxidation. Nutrition Research 1999;19:1121-32. (Pubitemid 29297738)
-
(1999)
Nutrition Research
, vol.19
, Issue.8
, pp. 1121-1132
-
-
Tuomainen, T.-P.1
Nyyssonen, K.2
Porkkala-Sarataho, E.3
Salonen, R.4
Baumgartner, J.A.5
Geisser, P.6
Salonen, J.T.7
-
14
-
-
37349054566
-
Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease
-
Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006;47(Suppl. 3):33-53.
-
(2006)
Am J Kidney Dis
, vol.47
, Issue.SUPPL. 3
, pp. 33-53
-
-
-
15
-
-
33646246606
-
Parenterale kolloidale Eisenkomplexprä parate
-
Jahn M, Roth S, Langguth P. Parenterale kolloidale Eisenkomplexprä parate. Dtsch Apoth Ztg 2006;146;1510-8.
-
(2006)
Dtsch Apoth Ztg
, vol.146
, pp. 1510-1518
-
-
Jahn, M.1
Roth, S.2
Langguth, P.3
-
16
-
-
77958585184
-
Clinical and economic outcomes in medicare beneficiaries with stage 3 or stage 4 chronic kidney disease and anemia: The role of intravenous iron therapy
-
Knight TG, Ryan K, Schaefer CP, D'Sylva L, et al. Clinical and economic outcomes in medicare beneficiaries with stage 3 or stage 4 chronic kidney disease and anemia: the role of intravenous iron therapy. J Manag Care Pharm 2010;16:605-15.
-
(2010)
J Manag Care Pharm
, vol.16
, pp. 605-615
-
-
Knight, T.G.1
Ryan, K.2
Schaefer, C.P.3
D'Sylva, L.4
-
17
-
-
49649099818
-
Ferumoxytol for treating iron deficiency anemia in CKD
-
Spinowitz BS, Kausz A, Baptista J, et al. Ferumoxytol for treating iron deficiency anemia in CKD. J Am Soc Nephrol 2008;19:1599-605.
-
(2008)
J Am Soc Nephrol
, vol.19
, pp. 1599-1605
-
-
Spinowitz, B.S.1
Kausz, A.2
Baptista, J.3
-
18
-
-
77956806828
-
The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: A review
-
Quinibi WY. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review. Arzneimittelforschung 2010;60:399-412.
-
(2010)
Arzneimittelforschung
, vol.60
, pp. 399-412
-
-
Quinibi, W.Y.1
-
19
-
-
9644257204
-
Structure, chemistry, and pharmacokinetics of intravenous iron agents
-
DOI 10.1097/01.ASN.0000143814.49713.C5
-
Danielson BG. Structure, chemistry, and pharmacokinetics of intravenous iron agents. J Am Soc Nephrol 2004;15:S93-S98. (Pubitemid 39578822)
-
(2004)
Journal of the American Society of Nephrology
, vol.15
, Issue.SUPPL. 2
-
-
Danielson, B.G.1
-
20
-
-
39349083683
-
Tolerability and efficacy of parenteral iron therapy in hemodialysis patients, a comparison of preparations
-
Moniem KA, Bhandari S. Tolerability and efficacy of parenteral iron therapy in hemodialysis patients, a comparison of preparations. Transfus Altern Transfus Med. 2007;9:37-42.
-
(2007)
Transfus Altern Transfus Med
, vol.9
, pp. 37-42
-
-
Moniem, K.A.1
Bhandari, S.2
-
21
-
-
0036280354
-
Parenteral iron formulations: A comperative toxicologic analysis and mechanisms of cell injury
-
Zager RA, Johnson ACM, Hanson SY, et al. Parenteral iron formulations: A comperative toxicologic analysis and mechanisms of cell injury. Am J Kidney Dis 2002;40:90-103.
-
(2002)
Am J Kidney Dis
, vol.40
, pp. 90-103
-
-
Zager, R.A.1
Johnson, A.C.M.2
Hanson, S.Y.3
-
22
-
-
77955248295
-
A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy
-
Khalafallah A, Dennis A, Bates J, et al. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. J Intern Med 2010;268:286-95.
-
(2010)
J Intern Med
, vol.268
, pp. 286-295
-
-
Khalafallah, A.1
Dennis, A.2
Bates, J.3
-
23
-
-
33845774779
-
A randomized controlled trial of oral versus intravenous iron in chronic kidney disease
-
DOI 10.1159/000096174
-
Agarwal R, Rizkala AR, Bastani B, et al. A randomized controlled trial of oral versus intravenous iron in chronic kidney disease. Am J Nephrol. 2006;26:445-54. (Pubitemid 44971735)
-
(2006)
American Journal of Nephrology
, vol.26
, Issue.5
, pp. 445-454
-
-
Agarwal, R.1
Rizkala, A.R.2
Bastani, B.3
Kaskas, M.O.4
Leehey, D.J.5
Besarab, A.6
-
24
-
-
80051920039
-
Safety Evaluation of Iron (Ferrlecit®, DexFerrum®, INFeD®) from 21,060,000 doses administered i.v., in the US 1998-2000
-
Ahlmén J, Vaage-Nilsen O. Safety Evaluation of Iron (Ferrlecit®, DexFerrum®, INFeD®) from 21,060,000 doses administered i.v., in the US 1998-2000. Nephrol Dial Transplant 2002;133:M305.
-
(2002)
Nephrol Dial Transplant
, vol.133
-
-
Ahlmén, J.1
Vaage-Nilsen, O.2
-
25
-
-
31544444964
-
Update on adverse drug events associated with parenteral iron
-
DOI 10.1093/ndt/gfi253
-
Chertow GM, Mason PD, Vaage-Nilsen O, et al. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 2006;21:378-82. (Pubitemid 43159991)
-
(2006)
Nephrology Dialysis Transplantation
, vol.21
, Issue.2
, pp. 378-382
-
-
Chertow, G.M.1
Mason, P.D.2
Vaage-Nilsen, O.3
Ahlmen, J.4
-
26
-
-
0035057037
-
Suspected iron dextran-related adverse drug events in hemodialysis patients
-
Fletes R, Lazarus JM, Gage J, et al. Suspected iron dextran-related adverse drug events in hemodialysis patients. Am J Kidney Dis 2001;37:743-9. (Pubitemid 32268035)
-
(2001)
American Journal of Kidney Diseases
, vol.37
, Issue.4
, pp. 743-749
-
-
Fletes, R.1
Lazarus, J.M.2
Gage, J.3
Chertow, G.M.4
-
27
-
-
39349106653
-
Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease
-
DOI 10.1038/sj.ki.5002779, PII 5002779
-
Auerbach M, Al Talib K. Low-molecular-weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. Kidney Int 2008;73:528-30. (Pubitemid 351264124)
-
(2008)
Kidney International
, vol.73
, Issue.5
, pp. 528-530
-
-
Auerbach, M.1
Al, T.K.2
-
28
-
-
77956855555
-
Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: A review of randomized controlled trials across different indications
-
Bailie GR. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications. Arzneimittelforschung 2010;60:386-98.
-
(2010)
Arzneimittelforschung
, vol.60
, pp. 386-398
-
-
Bailie, G.R.1
-
29
-
-
77956860272
-
The new generation of intravenous iron: Chemistry, pharmacology, and toxicology of ferric carboxymaltose
-
Funk F, Ryle P, Canclini C, et al. The new generation of intravenous iron: chemistry, pharmacology, and toxicology of ferric carboxymaltose. Arzneimittelforschung 2010;60:345-53.
-
(2010)
Arzneimittelforschung
, vol.60
, pp. 345-353
-
-
Funk, F.1
Ryle, P.2
Canclini, C.3
-
30
-
-
1342306211
-
Labile iron in parenteral iron formulations: A quantitative and comparative study
-
DOI 10.1093/ndt/gfg579
-
Van Wyck D, Anderson J, Johnson K. Labile iron in parenteral iron formulation: a quantitative and comparative study. Nephrol Dial Transplant 2004;19:561-5. (Pubitemid 38263113)
-
(2004)
Nephrology Dialysis Transplantation
, vol.19
, Issue.3
, pp. 561-565
-
-
Van Wyck, D.B.1
Anderson, J.2
Johnson, K.3
-
31
-
-
0029980758
-
"Oversaturation" of transferring after intravenous ferric gluconate (Ferrlecit®) in haemodialysis patients
-
Zanen AL, Adriaansen HJ, van Bommel EFH, et al. " Oversaturation" of transferring after intravenous ferric gluconate (Ferrlecit®) in haemodialysis patients. Nephrol Dial Transplant 1996;11:820-4.
-
(1996)
Nephrol Dial Transplant
, vol.11
, pp. 820-824
-
-
Zanen, A.L.1
Adriaansen, H.J.2
Van Bommel, E.F.H.3
-
32
-
-
33847282976
-
Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis
-
DOI 10.1592/phco.27.3.343
-
Pai AB, Boyd AV, McQuade CR, et al. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis. Pharmacotherapy 2007;27:343-50. (Pubitemid 46327902)
-
(2007)
Pharmacotherapy
, vol.27
, Issue.3
, pp. 343-350
-
-
Pai, A.B.1
Boyd, A.V.2
McQuade, C.R.3
Harford, A.4
Norenberg, J.P.5
Zager, P.G.6
-
33
-
-
79952200956
-
Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds
-
Toblli JE, Cao M, Olivieri L, Angerosa M. Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds. Nephrol Dial Transplant 2010;25:3631-40.
-
(2010)
Nephrol Dial Transplant
, vol.25
, pp. 3631-3640
-
-
Toblli, J.E.1
Cao, M.2
Olivieri, L.3
Angerosa, M.4
-
34
-
-
77955456688
-
Parenteral iron formulations differentially affect MCP-1, HO-1 and NGAL gene expression and renal responses to injury
-
Johnson ACM, Becker K, Zager RA. Parenteral iron formulations differentially affect MCP-1, HO-1 and NGAL gene expression and renal responses to injury. Am J Physiol Renal Physiol 2010;299:426-35.
-
(2010)
Am J Physiol Renal Physiol
, vol.299
, pp. 426-435
-
-
Johnson, A.C.M.1
Becker, K.2
Zager, R.A.3
-
35
-
-
0031753685
-
Saccharated ferric oxide-induced osteomalacia in Japan: Iron-induced osteopathy due to nephropathy
-
Sato K, Shiraki M. Saccharated ferric oxide-induced osteomalacia in Japan: Iron-induced osteopathy due to nephropathy. Endocrine J 1998;45:431-9. (Pubitemid 28477653)
-
(1998)
Endocrine Journal
, vol.45
, Issue.4
, pp. 431-439
-
-
Sato, K.1
Shiraki, M.2
-
37
-
-
74049101227
-
Differences between the original iron sucrose complex Venofer® and the iron sucrose similar Generis®, and potential implications
-
Toblli Je, Cao G, Oliveri L, et al. Differences between the original iron sucrose complex Venofer® and the iron sucrose similar Generis®, and potential implications. Port J Nephrol Hypert 2009;23:53-63.
-
(2009)
Port J Nephrol Hypert
, vol.23
, pp. 53-63
-
-
Toblli, Je.1
Cao, G.2
Oliveri, L.3
-
38
-
-
80051928987
-
Inflammatory response of generic iron sucrose complex preparations in kidney, liver and heart of normal rats
-
Toblli JE, Cao G, Olivieri L, et al. Inflammatory response of generic iron sucrose complex preparations in kidney, liver and heart of normal rats. Nephrol Dial Transplant 2006;21:160.
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 160
-
-
Toblli, J.E.1
Cao, G.2
Olivieri, L.3
-
39
-
-
66149166994
-
Differences between Original Intravenous Iron Sucrose and Iron Sucrose Similar Preparations
-
Toblli Je, Cao M, Oliveri L. Differences Between Original Intravenous Iron Sucrose and Iron Sucrose Similar Preparations. Arzneimittelforschung 2009;59:176-190.
-
(2009)
Arzneimittelforschung
, vol.59
, pp. 176-190
-
-
Toblli, Je.1
Cao, M.2
Oliveri, L.3
-
40
-
-
54349090164
-
Intravenous versus oral iron supplementation for the treatment of anemia in CKD: Systematic review and metaanalysis
-
Rosen-Zvi B, Gafter-Gvili A, Paul M, et al. Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and metaanalysis. Am J Kidney Dis 2008;52:897-906.
-
(2008)
Am J Kidney Dis
, vol.52
, pp. 897-906
-
-
Rosen-Zvi, B.1
Gafter-Gvili, A.2
Paul, M.3
-
41
-
-
77956857469
-
Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: A dose-escalation study in volunteers with mild iron-deficiency anaemia
-
Geisser P, Banké-Bochita J. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia. Arzneimittelforschung 2010;60:362-72.
-
(2010)
Arzneimittelforschung
, vol.60
, pp. 362-372
-
-
Geisser, P.1
Banké-Bochita, J.2
-
42
-
-
75149167105
-
Ferumoxytol: A new intravenous iron preparation for the treatment of iron deficiency anemia in patients with chronic kidney disease
-
Schwenk MH. Ferumoxytol: A new intravenous iron preparation for the treatment of iron deficiency anemia in patients with chronic kidney disease. Pharmacotherapy 2010;30:70-9.
-
(2010)
Pharmacotherapy
, vol.30
, pp. 70-79
-
-
Schwenk, M.H.1
-
43
-
-
77956802593
-
Pharmacodynamics and safety of ferric carboxymaltose: A multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder
-
Geisser P, Rumyantsev V. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder. Arzneimittelforschuhg 2010;60:373-85.
-
(2010)
Arzneimittelforschuhg
, vol.60
, pp. 373-385
-
-
Geisser, P.1
Rumyantsev, V.2
-
44
-
-
72449156527
-
Ferric carboxymaltose in patients with heart failure and iron deficiency
-
Anker SD, Colet JC, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009;361:1-13.
-
(2009)
N Engl J Med
, vol.361
, pp. 1-13
-
-
Anker, S.D.1
Colet, J.C.2
Filippatos, G.3
-
45
-
-
27544491237
-
Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure
-
DOI 10.1093/eurheartj/ehi388
-
Opasich C, Cazzola M, Scelsi L, et al. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J 2005;26:2232-7. (Pubitemid 41541385)
-
(2005)
European Heart Journal
, vol.26
, Issue.21
, pp. 2232-2237
-
-
Opasich, C.1
Cazzola, M.2
Scelsi, L.3
De Feo, S.4
Bosimini, E.5
Lagioia, R.6
Febo, O.7
Ferrari, R.8
Fucili, A.9
Moratti, R.10
Tramarin, R.11
Tavazzi, L.12
-
46
-
-
52949101033
-
Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: A randomized controlled clinical trial
-
Seid MH, et al. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. Am J Obstet Gynecol 2008;199;435:e1-7.
-
(2008)
Am J Obstet Gynecol
, vol.199
, Issue.435
-
-
Seid, M.H.1
-
47
-
-
71849101678
-
Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: A randomized, controlled trial
-
Van Wyck DB, Mangione A, Morrison J. et al. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion 2009;49:2719-28.
-
(2009)
Transfusion
, vol.49
, pp. 2719-2728
-
-
Van Wyck, D.B.1
Mangione, A.2
Morrison, J.3
-
48
-
-
34548462994
-
Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: A randomized controlled trial
-
DOI 10.1097/01.AOG.0000275286.03283.18, PII 0000625020070800000009
-
Van Wyck DB, Martens MG, Seid MH, et al. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia. Obstet Gynecol 2007;110:267-78. (Pubitemid 47356650)
-
(2007)
Obstetrics and Gynecology
, vol.110
, Issue.2 I
, pp. 267-278
-
-
Van Wyck, D.B.1
Martens, M.G.2
Seid, M.H.3
Baker, J.B.4
Mangione, A.5
-
49
-
-
40949107423
-
-
2. Aufl. Börm Bruckmeier Verlag
-
M. Imohl (Hrsg.). Labormedizin pocket. 2. Aufl. 2005; Börm Bruckmeier Verlag.
-
(2005)
Labormedizin Pocket
-
-
Imohl, M.1
-
50
-
-
80051937177
-
Hepcidin: Clinical utility as a diagnostic tool and therapeutic target
-
Coyne DW. Hepcidin: clinical utility as a diagnostic tool and therapeutic target. Kidney Int 2011;79:1
-
(2011)
Kidney Int
, vol.79
, pp. 1
-
-
Coyne, D.W.1
-
51
-
-
80051940762
-
Do two intravenous iron sucrose preparations have the same efficacy?
-
Feb 25 [epub ahead of print]
-
Rottembourg J, Kadri A, Leonard E, Dansaert A, et al. Do two intravenous iron sucrose preparations have the same efficacy? Nephrol Dial Transplant 2011 Feb 25 [epub ahead of print].
-
(2011)
Nephrol Dial Transplant
-
-
Rottembourg, J.1
Kadri, A.2
Leonard, E.3
Dansaert, A.4
-
52
-
-
79951865444
-
A comperative look at the safety profiles of intravenous iron products used in the hemodialysis population
-
Coppol E, Shelly J, Cheng S, Kaakeh Y, et al. A comperative look at the safety profiles of intravenous iron products used in the hemodialysis population. Ann Pharmacother 2011;45:241-7.
-
(2011)
Ann Pharmacother
, vol.45
, pp. 241-247
-
-
Coppol, E.1
Shelly, J.2
Cheng, S.3
Kaakeh, Y.4
|